Plasma Polymerized Prolinol Surfaces for Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing collagen-coated surfaces for cell culture are costly and not suitable for large-scale manufacturing, particularly in human therapeutic applications, due to the high cost of animal-derived collagen and peptide sequences that mimic collagen.
Innovation Solution
The development of animal-free, synthetic, chemically defined surfaces using plasma polymerization of prolinol or proline to create a surface that mimics collagen-coated surfaces, allowing for human hepatocyte attachment without additional extracellular matrix proteins, utilizing plasma polymerization or chemical vapor deposition techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal-derived collagen is used to coat surfaces for cell culture, then cell attachment is promoted, but the cost is very high and it is not suitable for large scale manufacturing
Solution Approach 1:
The patent creates a synthetic polymer coating that copies the cell attachment functionality of collagen without using actual collagen. The polymer is designed to mimic the surface properties and biochemical signals that enable cell attachment, providing a cost-effective alternative suitable for large-scale manufacturing while maintaining the desired biological function
Solution Approach 2:
The patent employs a synthetic polymer coating that can be applied as a disposable or single-use surface treatment. This approach eliminates the need for expensive, complex animal-derived collagen while providing sufficient functionality for cell culture applications, making the process economically viable for large-scale operations
2Reliability
If human collagen is used for coating surfaces, then cell attachment is promoted, but the cost is very high
Solution Approach 1:
The patent synthesizes a polymer coating that replicates the cell attachment properties of human collagen through molecular design rather than direct extraction. By copying only the essential functional characteristics at the molecular level, the invention achieves comparable biological performance at a fraction of the cost
Solution Approach 2:
The patent changes the material parameters from natural protein (collagen) to synthetic polymer, maintaining the surface chemistry and topography parameters that are critical for cell attachment while dramatically reducing the cost parameter through synthetic production methods
3Reliability
If peptide sequences that mimic collagen are used, then cell attachment is promoted, but the cost of producing such surfaces is relatively high and not suitable for large scale manufacturing
Solution Approach 1:
The patent breaks down the complex collagen structure into essential functional segments and recreates only those critical portions using simple synthetic polymer chemistry. This segmentation approach maintains the cell attachment functionality while enabling scalable production through straightforward polymerization processes
Solution Approach 2:
The patent transitions from peptide-based mimics to polymer-based coatings, changing the chemical parameter from short amino acid sequences to long-chain polymers. This parameter change simplifies the manufacturing process and enables large-scale production while preserving the surface properties necessary for cell attachment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces costs and enables large-scale manufacturing of surfaces that effectively mimic collagen-coated surfaces, facilitating human hepatocyte attachment and cell culture without the need for expensive animal-derived materials.
Implementation Method 1
creating a plasma of the monomer source; and contacting at least a portion of a surface with the plasma to provide a plasma polymer coated surface
Data Source
AI summary
The present invention discloses methods for producing synthetic surfaces that mimic collagen coated surfaces for cell culture comprising: providing a monomer source comprising one or more organic compounds which are capable of polymerization, wherein at least one organic compound is prolinol; creating a plasma of said monomer source; and contacting at least a portion of a surface with the plasma to provide a plasma polymer coated surface. Advantageously, such methods provide an animal-free, synthetic, chemically defined surface that mimics a collagen coated surface for cell culture. Advantageously, such methods not only reduce the cost and/or issues associated with animal-derived collagen but are also amenable to large scale manufacturing.